Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 137-142, January 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelley, J. J.
Right arrow Articles by Friedman, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelley, J. J.
Right arrow Articles by Friedman, O. M.

Studies on Latent Derivatives of Aminoethanethiols as Potentially Selective Cytoprotectants

II. In Vivo Distribution of Cysteamine Liberated in Rat Tissues1

John J. Kelley, Katherine A. Herrington, Samuel P. Ward, Alton Meister2 and Orrie M. Friedman

Collaborative Research, Inc., Waltham, Massachusetts

Preliminary evaluation of latent cytoprotectants as potentially useful chemotherapeutic compounds that would protect normal tissue against damaging effects of radiation or alkylating agents has involved examination of 11 candidate compounds for their capacity to release cysteamine after these compounds were injected into Sprague-Dawley rats. Cysteamine-S-phosphate and cysteamine-S-sulfate released substantial concentrations of cysteamine in a number of tissues, the former by an enzymatic process, the latter by a nonenzymatic mechanism. Only small concentrations of cysteamine were detected following the injection of N-acetylcysteamine, S-acetylcysteamine, N,S-diacetyl-cysteamine or 2-methylthiazoline. Little or no cysteamine was observed when the following compounds were tested: O-methyl-cysteamine-S-phosphate, and the N-(2-mercaptoethyl)carbamoyl derivatives of the amino acids phenylalanine, methionine, alanine, and ß-alanine. These data are correlated with available radiation protection information.

1 Supported by Research Contract PH43-62-170, Cancer Chemotherapy National Service Center, National Cancer Institute, NIH, Bethesda, Md.

2 Department of Biochemistry, Tufts University School of Medicine, Boston, Mass.

Received 5/ 3/66. Accepted 8/19/66.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. E. Jessop and N. J. Bulleid
Glutathione Directly Reduces an Oxidoreductase in the Endoplasmic Reticulum of Mammalian Cells
J. Biol. Chem., December 31, 2004; 279(53): 55341 - 55347.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.